Appreciate the point as I too am a long term sh. In my mind, the market deserved to be made aware of the companies intention and the forecast timeframe for making a submission following the advice from the FDA.
It is also reasonable to forecast an intent to submit in the second quarter. I would suggest that announcement that stated " we intend on filing submission in the second or third quarter' may have also raised the ire of shareholders, including myself, who would prefer a more definitive timeline and may have also afforded further opportunities for sp manipulation.
I much prefer an intent and commitment to endeavour to meet a second quarter submission target and be a couple of weeks late, than a qualification that it would be in the second or third quarter and be signalling an end september timeframe.
Not seeking to diminish others' concerns just offer a perspective on how I am viewing things at this point in time, to support my own investment thesis
V
Pick Today's Price Range Low-High... Just for Fun, page-621
Add MSB (ASX) to my watchlist
 (20min delay)
|
|||||
|
Last
$1.25 |
Change
0.035(2.89%) |
Mkt cap ! $1.421B | |||
| Open | High | Low | Value | Volume |
| $1.21 | $1.25 | $1.18 | $4.096M | 3.347M |
Buyers (Bids)
| No. | Vol. | Price($) |
|---|---|---|
| 1 | 22000 | $1.24 |
Sellers (Offers)
| Price($) | Vol. | No. |
|---|---|---|
| $1.25 | 36989 | 4 |
View Market Depth
| Last trade - 16.10pm 02/10/2024 (20 minute delay) ? |
| MSB (ASX) Chart |